Literature DB >> 12168931

The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.

Herzl Ben-Hur1, Ophir Cohen, David Schneider, Pavel Gurevich, Reuvit Halperin, Uri Bala, Marta Mozes, Itshak Zusman.   

Abstract

The objective of the present study was to analyze the function of lymphoid elements in the tumorigenesis of human breast cancer, similar to their elucidation in human ovarian cancer in our previous work. The lymphocytic and macrophageal content of lymphocytes and macrophages was analyzed immunohistochemically and morphometrically in 49 human breast tumors of different types. The following types of tumors were studied: 1) fibrocystic disease, 2) fibroadenoma, 3) carcinoma in situ, 4) infiltrating ductal and lobular carcinoma with high lymphoid infiltration, and 5) infiltrating ductal and lobular carcinoma with lymphoid depletion. The first two had little lymphoid infiltration and few lymphocytes (mainly T cells), while carcinoma in situ had extensive lymphoid infiltration and increased lymphocytic density, the consequence of a sharp rise in total lymphocytes reflecting the intensified immune response. In ductal and lobular infiltrating carcinoma with high infiltration, T cells were in large excess of B cells (81% and 87% vs. 11%) and CD8+ lymphocytes were the predominant type of T cells (up to 90%), in both tumoral parenchyma and stroma. In infiltrating carcinoma with lymphoid depletion, the total lymphocyte and macrophage count and areas of lymphoid infiltrates decreased, relative to highly infiltrated carcinomas, as signs of deep subcompensation of the lymphoid system. The host's reaction to disease was reflected in high correlations between the densities of the lymphoid cellular elements as tumorigenesis evolved. We suggest that the stromal immunocompetent cells are a reservoir of T killers that eventually cross into the parenchyma and join T helpers and B lymphocytes in the immune antitumor response. In later stages of cancer the response is exhausted, as manifested in lymphoid subcompensation.

Entities:  

Mesh:

Year:  2002        PMID: 12168931

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues.

Authors:  P Fierabracci; A Pinchera; D Campani; L E Pollina; E Giustarini; C Giani
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

2.  Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.

Authors:  Peter Simsa; Jean-Luc Teillaud; David I Stott; József Tóth; Beatrix Kotlan
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

Authors:  S Derniame; J-M Vignaud; G C Faure; M C Béné
Journal:  Clin Exp Immunol       Date:  2008-08-29       Impact factor: 4.330

4.  Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.

Authors:  Michael D Iglesia; Benjamin G Vincent; Joel S Parker; Katherine A Hoadley; Lisa A Carey; Charles M Perou; Jonathan S Serody
Journal:  Clin Cancer Res       Date:  2014-06-10       Impact factor: 12.531

5.  Diffusion-weighted imaging reflects variable cellularity and stromal density present in breast fibroadenomas.

Authors:  Sana Parsian; Nadia V Giannakopoulos; Habib Rahbar; Mara H Rendi; Xiaoyu Chai; Savannah C Partridge
Journal:  Clin Imaging       Date:  2016-06-13       Impact factor: 1.605

6.  Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.

Authors:  Thérèse Rachell Theodoro; Leandro Luongo de Matos; Aleksandra Vanessa Lambiasi Sant Anna; Fernando Luiz Affonso Fonseca; Patrícia Semedo; Lourdes Conceição Martins; Helena Bonciani Nader; Auro Del Giglio; Maria Apareci da Silva Pinhal
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

7.  CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Authors:  Shuzhen Liu; Jonathan Lachapelle; Samuel Leung; Dongxia Gao; William D Foulkes; Torsten O Nielsen
Journal:  Breast Cancer Res       Date:  2012-03-15       Impact factor: 6.466

8.  Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients.

Authors:  Stine L Figenschau; Silje Fismen; Kristin A Fenton; Christopher Fenton; Elin S Mortensen
Journal:  BMC Cancer       Date:  2015-03-06       Impact factor: 4.430

9.  Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.

Authors:  Yan-gao Man; Lisa Tai; Ross Barner; Russell Vang; Jeffrey S Saenger; Kris M Shekitka; Gary L Bratthauer; Darren T Wheeler; Chang Y Liang; Tuyethoa N Vinh; Brian L Strauss
Journal:  Breast Cancer Res       Date:  2003-10-03       Impact factor: 6.466

10.  Immune cell quantitation in normal breast tissue lobules with and without lobulitis.

Authors:  Amy C Degnim; Rushin D Brahmbhatt; Derek C Radisky; Tanya L Hoskin; Melody Stallings-Mann; Mark Laudenschlager; Aaron Mansfield; Marlene H Frost; Linda Murphy; Keith Knutson; Daniel W Visscher
Journal:  Breast Cancer Res Treat       Date:  2014-03-05       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.